世界のT細胞療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global T-Cell Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4937
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、T細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCR療法、TIL療法）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・T細胞療法の市場動向
・企業の競争状況、市場シェア
・T細胞療法の種類別市場規模と予測2016-2027（CAR T細胞療法、TCR療法、TIL療法）
・T細胞療法の用途別市場規模と予測2016-2027（病院、診療所・外来センター、がん研究所、その他）
・T細胞療法の北米市場規模2016-2027（アメリカ、カナダ）
・T細胞療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・T細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・T細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・T細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Gilead Sciences, Inc.、Sorrento Therapeutics、Fate Therapeutics Inc.、Novartis International AG、AbbVie Inc.、Adaptimmune Therapeutics PLC、Bluebird Bio、TCR2 Therapeutics, Inc.、Pfizer Inc.、DiaCarta, Inc.）
・結論

Market Analysis and Insights: Global T-Cell Therapy Market
The global T-Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global T-Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global T-Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global T-Cell Therapy market.

Global T-Cell Therapy Scope and Market Size
T-Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global T-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CAR T Cell Therapy
TCR Therapy
TIL Therapy

Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CAR T Cell Therapy
1.2.3 TCR Therapy
1.2.4 TIL Therapy
1.3 Market by Application
1.3.1 Global T-Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global T-Cell Therapy Market Perspective (2016-2027)
2.2 T-Cell Therapy Growth Trends by Regions
2.2.1 T-Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 T-Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 T-Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 T-Cell Therapy Industry Dynamic
2.3.1 T-Cell Therapy Market Trends
2.3.2 T-Cell Therapy Market Drivers
2.3.3 T-Cell Therapy Market Challenges
2.3.4 T-Cell Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top T-Cell Therapy Players by Revenue
3.1.1 Global Top T-Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global T-Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by T-Cell Therapy Revenue
3.4 Global T-Cell Therapy Market Concentration Ratio
3.4.1 Global T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Therapy Revenue in 2020
3.5 T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players T-Cell Therapy Product Solution and Service
3.7 Date of Enter into T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Therapy Breakdown Data by Type
4.1 Global T-Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global T-Cell Therapy Forecasted Market Size by Type (2022-2027)

5 T-Cell Therapy Breakdown Data by Application
5.1 Global T-Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global T-Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America T-Cell Therapy Market Size (2016-2027)
6.2 North America T-Cell Therapy Market Size by Type
6.2.1 North America T-Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America T-Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America T-Cell Therapy Market Size by Type (2016-2027)
6.3 North America T-Cell Therapy Market Size by Application
6.3.1 North America T-Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America T-Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America T-Cell Therapy Market Size by Application (2016-2027)
6.4 North America T-Cell Therapy Market Size by Country
6.4.1 North America T-Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America T-Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe T-Cell Therapy Market Size (2016-2027)
7.2 Europe T-Cell Therapy Market Size by Type
7.2.1 Europe T-Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe T-Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe T-Cell Therapy Market Size by Type (2016-2027)
7.3 Europe T-Cell Therapy Market Size by Application
7.3.1 Europe T-Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe T-Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe T-Cell Therapy Market Size by Application (2016-2027)
7.4 Europe T-Cell Therapy Market Size by Country
7.4.1 Europe T-Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe T-Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific T-Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific T-Cell Therapy Market Size by Type
8.2.1 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific T-Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific T-Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific T-Cell Therapy Market Size by Application
8.3.1 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific T-Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific T-Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific T-Cell Therapy Market Size by Region
8.4.1 Asia-Pacific T-Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific T-Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America T-Cell Therapy Market Size (2016-2027)
9.2 Latin America T-Cell Therapy Market Size by Type
9.2.1 Latin America T-Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America T-Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America T-Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America T-Cell Therapy Market Size by Application
9.3.1 Latin America T-Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America T-Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America T-Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America T-Cell Therapy Market Size by Country
9.4.1 Latin America T-Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America T-Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa T-Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa T-Cell Therapy Market Size by Type
10.2.1 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa T-Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa T-Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa T-Cell Therapy Market Size by Application
10.3.1 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa T-Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa T-Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa T-Cell Therapy Market Size by Country
10.4.1 Middle East & Africa T-Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa T-Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead Sciences, Inc.
11.1.1 Gilead Sciences, Inc. Company Details
11.1.2 Gilead Sciences, Inc. Business Overview
11.1.3 Gilead Sciences, Inc. T-Cell Therapy Introduction
11.1.4 Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.1.5 Gilead Sciences, Inc. Recent Development
11.2 Sorrento Therapeutics
11.2.1 Sorrento Therapeutics Company Details
11.2.2 Sorrento Therapeutics Business Overview
11.2.3 Sorrento Therapeutics T-Cell Therapy Introduction
11.2.4 Sorrento Therapeutics Revenue in T-Cell Therapy Business (2016-2021)
11.2.5 Sorrento Therapeutics Recent Development
11.3 Fate Therapeutics Inc.
11.3.1 Fate Therapeutics Inc. Company Details
11.3.2 Fate Therapeutics Inc. Business Overview
11.3.3 Fate Therapeutics Inc. T-Cell Therapy Introduction
11.3.4 Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.3.5 Fate Therapeutics Inc. Recent Development
11.4 Novartis International AG
11.4.1 Novartis International AG Company Details
11.4.2 Novartis International AG Business Overview
11.4.3 Novartis International AG T-Cell Therapy Introduction
11.4.4 Novartis International AG Revenue in T-Cell Therapy Business (2016-2021)
11.4.5 Novartis International AG Recent Development
11.5 AbbVie Inc.
11.5.1 AbbVie Inc. Company Details
11.5.2 AbbVie Inc. Business Overview
11.5.3 AbbVie Inc. T-Cell Therapy Introduction
11.5.4 AbbVie Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.5.5 AbbVie Inc. Recent Development
11.6 Adaptimmune Therapeutics PLC
11.6.1 Adaptimmune Therapeutics PLC Company Details
11.6.2 Adaptimmune Therapeutics PLC Business Overview
11.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Introduction
11.6.4 Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2016-2021)
11.6.5 Adaptimmune Therapeutics PLC Recent Development
11.7 Bluebird Bio
11.7.1 Bluebird Bio Company Details
11.7.2 Bluebird Bio Business Overview
11.7.3 Bluebird Bio T-Cell Therapy Introduction
11.7.4 Bluebird Bio Revenue in T-Cell Therapy Business (2016-2021)
11.7.5 Bluebird Bio Recent Development
11.8 TCR2 Therapeutics, Inc.
11.8.1 TCR2 Therapeutics, Inc. Company Details
11.8.2 TCR2 Therapeutics, Inc. Business Overview
11.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Introduction
11.8.4 TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.8.5 TCR2 Therapeutics, Inc. Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. T-Cell Therapy Introduction
11.9.4 Pfizer Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
11.10 DiaCarta, Inc.
11.10.1 DiaCarta, Inc. Company Details
11.10.2 DiaCarta, Inc. Business Overview
11.10.3 DiaCarta, Inc. T-Cell Therapy Introduction
11.10.4 DiaCarta, Inc. Revenue in T-Cell Therapy Business (2016-2021)
11.10.5 DiaCarta, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global T-Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CAR T Cell Therapy
Table 3. Key Players of TCR Therapy
Table 4. Key Players of TIL Therapy
Table 5. Global T-Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global T-Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global T-Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global T-Cell Therapy Market Share by Regions (2016-2021)
Table 9. Global T-Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global T-Cell Therapy Market Share by Regions (2022-2027)
Table 11. T-Cell Therapy Market Trends
Table 12. T-Cell Therapy Market Drivers
Table 13. T-Cell Therapy Market Challenges
Table 14. T-Cell Therapy Market Restraints
Table 15. Global T-Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global T-Cell Therapy Market Share by Players (2016-2021)
Table 17. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Therapy as of 2020)
Table 18. Ranking of Global Top T-Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by T-Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players T-Cell Therapy Product Solution and Service
Table 22. Date of Enter into T-Cell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global T-Cell Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global T-Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global T-Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global T-Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global T-Cell Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global T-Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global T-Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific T-Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific T-Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa T-Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa T-Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa T-Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa T-Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa T-Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa T-Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Gilead Sciences, Inc. Company Details
Table 63. Gilead Sciences, Inc. Business Overview
Table 64. Gilead Sciences, Inc. T-Cell Therapy Product
Table 65. Gilead Sciences, Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 66. Gilead Sciences, Inc. Recent Development
Table 67. Sorrento Therapeutics Company Details
Table 68. Sorrento Therapeutics Business Overview
Table 69. Sorrento Therapeutics T-Cell Therapy Product
Table 70. Sorrento Therapeutics Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 71. Sorrento Therapeutics Recent Development
Table 72. Fate Therapeutics Inc. Company Details
Table 73. Fate Therapeutics Inc. Business Overview
Table 74. Fate Therapeutics Inc. T-Cell Therapy Product
Table 75. Fate Therapeutics Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 76. Fate Therapeutics Inc. Recent Development
Table 77. Novartis International AG Company Details
Table 78. Novartis International AG Business Overview
Table 79. Novartis International AG T-Cell Therapy Product
Table 80. Novartis International AG Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 81. Novartis International AG Recent Development
Table 82. AbbVie Inc. Company Details
Table 83. AbbVie Inc. Business Overview
Table 84. AbbVie Inc. T-Cell Therapy Product
Table 85. AbbVie Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 86. AbbVie Inc. Recent Development
Table 87. Adaptimmune Therapeutics PLC Company Details
Table 88. Adaptimmune Therapeutics PLC Business Overview
Table 89. Adaptimmune Therapeutics PLC T-Cell Therapy Product
Table 90. Adaptimmune Therapeutics PLC Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 91. Adaptimmune Therapeutics PLC Recent Development
Table 92. Bluebird Bio Company Details
Table 93. Bluebird Bio Business Overview
Table 94. Bluebird Bio T-Cell Therapy Product
Table 95. Bluebird Bio Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 96. Bluebird Bio Recent Development
Table 97. TCR2 Therapeutics, Inc. Company Details
Table 98. TCR2 Therapeutics, Inc. Business Overview
Table 99. TCR2 Therapeutics, Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 100. TCR2 Therapeutics, Inc. Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. T-Cell Therapy Product
Table 104. Pfizer Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 105. Pfizer Inc. Recent Development
Table 106. DiaCarta, Inc. Company Details
Table 107. DiaCarta, Inc. Business Overview
Table 108. DiaCarta, Inc. T-Cell Therapy Product
Table 109. DiaCarta, Inc. Revenue in T-Cell Therapy Business (2016-2021) & (US$ Million)
Table 110. DiaCarta, Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. CAR T Cell Therapy Features
Figure 3. TCR Therapy Features
Figure 4. TIL Therapy Features
Figure 5. Global T-Cell Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics & Ambulatory Centers Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. T-Cell Therapy Report Years Considered
Figure 11. Global T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global T-Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global T-Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global T-Cell Therapy Market Share by Regions (2022-2027)
Figure 15. Global T-Cell Therapy Market Share by Players in 2020
Figure 16. Global Top T-Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T-Cell Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by T-Cell Therapy Revenue in 2020
Figure 18. Global T-Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global T-Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America T-Cell Therapy Market Share by Type (2016-2027)
Figure 22. North America T-Cell Therapy Market Share by Application (2016-2027)
Figure 23. North America T-Cell Therapy Market Share by Country (2016-2027)
Figure 24. United States T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe T-Cell Therapy Market Share by Type (2016-2027)
Figure 28. Europe T-Cell Therapy Market Share by Application (2016-2027)
Figure 29. Europe T-Cell Therapy Market Share by Country (2016-2027)
Figure 30. Germany T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific T-Cell Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific T-Cell Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific T-Cell Therapy Market Share by Region (2016-2027)
Figure 40. China T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America T-Cell Therapy Market Share by Type (2016-2027)
Figure 48. Latin America T-Cell Therapy Market Share by Application (2016-2027)
Figure 49. Latin America T-Cell Therapy Market Share by Country (2016-2027)
Figure 50. Mexico T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa T-Cell Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa T-Cell Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa T-Cell Therapy Market Share by Country (2016-2027)
Figure 56. Turkey T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE T-Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Gilead Sciences, Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 60. Sorrento Therapeutics Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 61. Fate Therapeutics Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 62. Novartis International AG Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 63. AbbVie Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 64. Adaptimmune Therapeutics PLC Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 65. Bluebird Bio Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 66. TCR2 Therapeutics, Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 67. Pfizer Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 68. DiaCarta, Inc. Revenue Growth Rate in T-Cell Therapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の自己細胞療法市場規模・現状・予測（2021年-2027年）

Global Autologous Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3873 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、自己細胞療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（骨髄、表皮）、用途別市場規模（神経内科、整形外科、がん、創傷治癒、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Allogeneic Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3781 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、同種異系幹細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（成体幹細胞治療、ヒト胚性幹細胞治療、人工多能性幹細胞治療、その他）、用途別市場規模（筋骨格系障害、傷＆怪我、心血管疾患、その他）、主要...

世界のマントル細胞リンパ腫治療薬市場規模・現状・予測（2021年-2027年）

Global Mantle Cell Lymphoma Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5839 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、マントル細胞リンパ腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3985 2021年6月 119Pages
QYResearch社発行の本調査レポートでは、細胞＆遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（希少疾患、腫瘍、血液、心臓血管、眼科、神経、その他）、用途別市場規模（製薬＆バイオテクノロジー企業、研究＆学術機関、委託研究機関（CRO...

世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年）

Global Cell and Gene Therapy Tools and Reagents Market Size, Status and Forecast 2021-2027
QFJ1-5121 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、細胞・遺伝子治療用ツール＆試薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学発光免疫測定法（CLIA）、フルオロイムノアッセイ、マルチプレックスアッセイ、迅速診断技術）、用途別市場規模（病院、研...

世界のTCR療法市場規模・現状・予測（2021年-2027年）

Global TCR Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4939 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、TCR療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（キメラ抗原受容体シグナル伝達、TCRα/βヘテロダイマーシグナル伝達）、用途別市場規模（病院、診療所・外来センター、がん研究所、その他）、主要...

世界のナチュラルキラー（NK）細胞治療市場規模・現状・予測（2021年-2027年）

Global Natural Killer (NK) Cell Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5876 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ナチュラルキラー（NK）細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モガムリズマブ、ロルボツズマブメルタンシン、その他）、用途別市場規模（がん、循環器疾患、その他）、主要地域別市場規模（北...

世界の自家幹細胞＆非幹細胞系治療法市場規模・現状・予測（2021年-2027年）

Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3876 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、自家幹細胞＆非幹細胞系治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞治療、非幹細胞治療）、用途別市場規模（がん、神経変性疾患、循環器疾患、自己免疫疾患、その他）、主要地域別市場規模（...

世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027
QFJ1-5750 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界のT細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global T-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4936 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、T細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、外科療法、幹細胞移植療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模...

世界の自己細胞療法市場規模・現状・予測（2021年-2027年） Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is t…
世界の細胞・遺伝子治療用ツール＆試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cell and Gene Therapy Tools and Reagents Market The global Cell and Gene Therapy Tools and Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…
世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の細胞＆遺伝子治療市場規模・現状・予測（2021年-2027年） Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting …
世界の腎臓癌治療市場規模・現状・予測（2021年-2027年） Kidney cancer -- also called renal cancer -- is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma…